Page last updated: 2024-11-05

trihexyphenidyl and Puerperal Disorders

trihexyphenidyl has been researched along with Puerperal Disorders in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Subramanyam, AA1
Nachane, HB1
Mahajan, NN1
Shinde, S1
D Mahale, S1
Gajbhiye, RK1

Other Studies

1 other study available for trihexyphenidyl and Puerperal Disorders

ArticleYear
Postpartum psychosis in mothers with SARS-CoV-2 infection: A case series from India.
    Asian journal of psychiatry, 2020, Volume: 54

    Topics: Antipsychotic Agents; Asymptomatic Infections; COVID-19; Delusions; Female; Hallucinations; Haloperi

2020